 |
|
||||
 |
Acrodose™ Systems for Pre-storage Pooling and Testing of Whole Blood Derived Platelets | |
 | |
As a leader in whole blood collection and filtration system solutions, Pall Medical was the first to introduce the Acrodose PL System, a pre-storage whole blood platelet pooling system, in the USA for the efficient manufacture of high-quality Acrodose Platelets. Now, Pall Medical expands the options with the introduction of the Acrodose PLus System with integrated leukoreduction filtration, combining all the essential ingredient - filtration, pooling and bacteria testing, into one complete design.
- Customer Perspectives on Acrodose PL System Benefits
- Two Approaches to Making An AcrodoseSM Platelet...
- What is an Acrodose Platelet?
- Components and Specifications
- Consistent and Reliable Performance: Bacteria Testing Data
- Literature and Technical Papers
- Training and Implementation
- Complementary Products
Top
Filtering Platelet Concentrates with the Leukotrap RC PL or PL Systems
- Leukoreduction
Leukotrap RC PL and PL Systems are the only closed systems capable of producing leukoreduced CP2D whole blood platelets designed to work with the Acrodose PL System - Pooling and Storing
The Acrodose PL System provides pre-storage pooling of leukoreduced whole blood-derived platelets. - Bacteria Detection and Data Management
Pall eBDS* provides unsurpassed sensitivity and specificity in bacteria detection with minimal platelet loss.
Pall Data captures the ouput from Pall eBDS and allows the information to be queried into a user-defined report.
*Customer may use an alternative market-cleared bacteria detection system.
Another Approach: Using the Acrodose™ PLus System
Filtering the Platelet Pool with the Acrodose PL Leukocyte Reduction Filter
- Collection
Produce non-leukoreduced whole blood platelets from either:
- Pall collection systems, such as the Leukotrap RC System with RC2D Filter, or
- Any collection system using CPD anticoagulant - Bacteria Detection and Data Management
Pall eBDS allows for detection of bacteria in the prefiltered, non-leukoreduced pool, providing the maximum shelf life of the final platelet.
Pall Data captures the ouput from Pall eBDS and allows the information to be queried into a user-defined report. - Leukoreduction, Pooling and Storing
The Acrodose PLus System provides closed-system prestorage filtration of non-leukoreduced CPD or CP2D whole blood platelets – resulting in a pool of leukoreduced whole blood platelets.
Top
An AcrodoseSM Platelet represents a “transfusion ready” platelet for the hospital that is leukoreduced, ABO matched, pooled and bacteria tested. It enhances patient safety with culture-based bacteria testing for whole blood derived platelets. It also lowers hospital handling costs by eliminating the need for pooling and bacteria testing at the hospital. Read more...Top
.gif)
Top
Using a platform of complementary products, blood collection facilities are able to produce a therapeutic dose of platelets that are pooled, leukoreduced, ABO matched, and bacteria tested with culture based detection methods – in other words, an Acrodose Platelet. Read more about:
- An AcrodoseSM Platelet
- Collecting and Processing: Leukotrap® RC PL and Leukotrap PL Systems
- Bacteria Detection and Management: Pall eBDS and Pall Data
For the full story, go to A New Platform for Platelet Transfusion Safety.
Top